Efficacy and extrapyramidal side-effects of the new antipsychotics olanzapine, quetiapine, risperidone, and sertindole compared to conventional antipsychotics and placebo. A meta-analysis of randomized controlled trials
- 8 December 1998
- journal article
- research article
- Published by Elsevier in Schizophrenia Research
- Vol. 35 (1) , 51-68
- https://doi.org/10.1016/s0920-9964(98)00105-4
Abstract
No abstract availableKeywords
This publication has 72 references indexed in Scilit:
- Multiple fixed doses of “Seroquel” (quetiapine) in patients with acute exacerbation of schizophrenia: A comparison with haloperidol and placeboBiological Psychiatry, 1997
- New Dimensions in the Pharmacologic Treatment of Schizophrenia and Related PsychosesThe Journal of Clinical Pharmacology, 1997
- Olanzapine versus haloperidol: acute phase results of the international double-blind olanzapine trialEuropean Neuropsychopharmacology, 1997
- Treatment of schizophrenic disorders: Algorithms for acute pharmacotherapyInternational Journal of Psychiatry in Clinical Practice, 1997
- ICI 204,636, an Atypical AntipsychoticJournal of Clinical Psychopharmacology, 1996
- Olanzapine versus placebo: results of a double-blind, fixed-dose olanzapine trialPsychopharmacology, 1996
- Olanzapine versus Placebo and HaloperidolNeuropsychopharmacology, 1996
- Clinical Efficacy of Serotonin-Dopamine Antagonists Relative to Classic NeurolepticsJournal of Clinical Psychopharmacology, 1995
- Significance of Neuroleptic Dose and Plasma Level in the Pharmacological Treatment of PsychosesArchives of General Psychiatry, 1988
- Negative Symptoms in SchizophreniaArchives of General Psychiatry, 1982